Rituxan (rituximab) is a type of antibody therapy (biologic) medication that may be used with or without chemotherapy. It destroys or helps your body destroy blood cells that contain cancer. It’s used ...
LOS ANGELES (Reuters) - Continued use of Rituxan cut by about 50 percent the risk that follicular lymphoma patients would have their cancer return, according to a late-stage study of the drug, which ...
LOS ANGELES, Dec 5 (Reuters) - A trial of Roche Holding's The typical practice for patients with such advanced-stage follicular lymphoma has been a watchful-waiting approach in which use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback